
Summary:
In this podcast, recorded at the 2024 Patients as Partners Europe conference, GSK and Ovacome present how they developed a unique, mutually beneficial partnership that allowed GSK to explore the entire patient experience when living with a disease in a real-world setting, and gain insights from patient organizations to drive actionable change within clinical research. The Ovacome-GSK partnership impacted the full product lifecycle, by focusing on the entire patient experience, not just the narrow amount of time they're eligible for a trial.
This presentation covers the impact of a pharma-patient organization partnership on:
- Patient Engagement Tools
- Addressing Health Inequality within the patient community
- Real-world evidence generation
Related Podcasts
View All
Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?

Biogen Pilot on Using Vocal Biomarkers to Identify Potential Trial Participants: From the DPHARM 2024 Archives

Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives
